Retronectin®-assisted retroviral transduction of primary human T lymphocytes under good manufacturing practice conditions: tissue culture bag critically determines cell yield

By Lamers CHJ   van Elzakker P.   van Steenbergen SCL   Sleijfer S.   Debets R.   Gratama JW  

Cytotherapy, Vol. 10, Iss. 4, 2008-01 ,pp. : 406-416

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Engineered CD20-specific primary human cytotoxic T lymphocytes for targeting B-cell malignancy

By Jensen Mc   Cooper Ljn   Wu Am   Forman Sj   Raubitschek A  

Cytotherapy, Vol. 5, Iss. 2, 2003-01 ,pp. : 131-138

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Expansion of human CMV-specific cytotoxic T lymphocytes to a clinical scale: a simple culture system using tetrameric HLA-peptide complexes

By Watanabe N   Kamachi Y   Koyama N   Hama A   Liang J   Nakamura Y   Yamamoto T   Isomura M   Kudo K   Kuzushima K   Kojima S  

Cytotherapy, Vol. 6, Iss. 5, 2004-10 ,pp. : 514-522

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Good manufacturing practice-grade cytotoxic T lymphocytes specific for latent membrane proteins (LMP)-1 and LMP2 for patients with Epstein––Barr virus-associated lymphoma

By Bollard Catherine M.   Gottschalk Stephen   Helen Huls M.   Leen Ann M.   Gee Adrian P.   Rooney Cliona M.  

Cytotherapy, Vol. 13, Iss. 5, 2011-05 ,pp. : 518-522

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Generation of Ag-specific cytotoxic T lymphocytes by DC transfected with in vitro transcribed influenza virus matrix protein (M1) mRNA

By Osman Y   Narita M   Ayres F   Takahashi M   Alldawi L   Tatsuo F   Toba K   Hirohashi T   Aizawa Y  

Cytotherapy, Vol. 5, Iss. 2, 2003-01 ,pp. : 161-168

Ashgate Publishing Ltd

Access to resources Recommend Favorite